Clinical Trial Update: The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of cannabidiol and homotaurine in patients with mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Cannabidiol (cannabidiol)
• Homotaurine (homotaurine)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Mild Cognitive Impairment | Phase 4 | Status: UNKNOWN